Art has 25 years of experience in the medical device industry as a CEO, a COO, a CFO, and other senior-level operational and financial positions for both publicly held companies and private venture capital-backed firms. Art has extensive operational and leadership experience in both large and small commercial-stage companies and in pre-revenue clinical or development startup companies. Sector experiences include spine, electrophysiology, ophthalmology, hearing health care, and neurology. In addition to Relievant, Art currently serves as a member of the Board of Directors for Providence Medical, Neuspera, and Resonea, Inc.